GenMark Diagnostics to Attend Canaccord Genuity's 37th Annual Growth Conference

July 31, 2017

CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, announced today that President and Chief Executive Officer, Hany Massarany, will attend the 2017 Canaccord Genuity Growth Conference in Boston. Mr. Massarany will participate in an analyst-led fireside chat on Wednesday, August 9 at 8:00 AM Eastern Time.


GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of multiplex molecular diagnostic solutions designed to enhance patient care, improve key quality metrics, and reduce the total cost-of-care. Utilizing GenMark's proprietary eSensor® detection technology, GenMark's eSensor XT-8® and ePlex® systems are designed to support a broad range of molecular diagnostic tests with compact, easy-to-use workstations and self-contained, disposable test cartridges. GenMark's ePlex: The True Sample-to-Answer Solution™ is designed to optimize laboratory efficiency and address a broad range of infectious disease testing needs, including respiratory, bloodstream, and gastrointestinal infections. For more information, visit

GenMark Diagnostics, Inc.
Hany Massarany
President, Chief Executive Officer

Source: GenMark Diagnostics, Inc.

News Provided by Acquire Media